Co-Pay and Financial
BMS Access Support® can help identify financial assistance programs for eligible patients who have been prescribed EMPLICITI and who need help managing the cost of treatment. The appropriate program will depend on the patient’s coverage.
Patients With Commercial (Private) Insurance
The BMS Oncology Co-Pay Assistance Program helps commercially insured patients who have been prescribed select BMS medications with out-of-pocket deductibles, co-pays, or co-insurance requirements. Eligible patients may pay as little as $25 per infusion, up to a maximum of $25,000 per calendar year.
For more information, please call BMS Access Support® at 1-800-861-0048, 8 am–8 pm ET, Monday–Friday.
Restrictions apply. Please click here for full Terms and Conditions, including complete eligibility requirements.
Patients With Insurance Through Federal Healthcare Programs
- Patients insured through Federal Healthcare Programs are not eligible for co-pay assistance programs sponsored by Bristol Myers Squibb.
- BMS Access Support can make a referral to independent charitable foundations offering support for your specific patient. Please contact BMS Access Support at 1-800-861-0048 for details.
Patients Without Prescription Drug Coverage or Who Are Underinsured
- For patients without prescription drug insurance or for patients who are underinsured, BMS Access Support can make a referral to independent charitable foundations that may be able to help.
- The Bristol Myers Squibb Patient Assistance Foundation (BMSPAF), a charitable organization, may also provide medicine, free of charge, to eligible, uninsured patients who have an established financial hardship. For more information and eligibility criteria, visit bmspaf.org.
It is important to note that charitable foundations are independent from Bristol-Myers Squibb Company. Each foundation has its own eligibility criteria and evaluation process. Bristol Myers Squibb cannot guarantee that a patient will receive assistance.
The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.